Hedge Funds Are Buying These 4 Stocks Under $5 With Encouraging Sales Trends

3. Novavax, Inc. ( NVAX): Focuses on developing recombinant vaccines for infectious diseases using its virus-like particle platform technology. Market cap at $300.32M, most recent closing price at $2.03. Net institutional purchases in the current quarter at 11.1M shares, which represents about 10.19% of the company's float of 108.88M shares. Revenue grew by 14.97% during the most recent quarter ($5.76M vs. $5.01M y/y). Accounts receivable grew by 8.27% during the same time period ($4.19M vs. $3.87M y/y). Receivables, as a percentage of current assets, decreased from 14.74% to 11.49% during the most recent quarter (comparing 3 months ending 2012-09-30 to 3 months ending 2011-09-30).

4. Power-One Inc. ( PWER): Designs, manufactures, and markets power conversion and power management solutions for the renewable energy (RE), communications infrastructure, and other technology markets. Market cap at $476.12M, most recent closing price at $3.92. Net institutional purchases in the current quarter at 8.8M shares, which represents about 8.73% of the company's float of 100.84M shares. Revenue grew by 15.76% during the most recent quarter ($283.65M vs. $245.03M y/y). Accounts receivable grew by 7.98% during the same time period ($256.83M vs. $237.84M y/y). Receivables, as a percentage of current assets, decreased from 39.81% to 34.42% during the most recent quarter (comparing 13 weeks ending 2012-09-30 to 13 weeks ending 2011-10-02).
 

 

(List compiled by Kapitall's Sabina Bhatia.  Accounting data sourced from Google Finance, institutional data from Fidelity, all other data sourced from Finviz.)